Combined Noninvasive Respiratory Support Therapies to Treat COVID-19.
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Colaianni-Alfonso, N
- Montiel, G
- Castro-Sayat, M
- Siroti, C
- Laura Vega, Maria
- Toledo, A
- Haedo, S
- Previgliano, I
Grupos
Abstract
The roles of high-flow nasal cannula (HFNC) and CPAP in coronavirus disease 2019 (COVID-19) are controversial. The objective of the study was to evaluate the impact of the application of a noninvasive respiratory support algorithm on clinical outcomes in subjects with COVID-19 and with acute respiratory failure.
Datos de la publicación
- ISSN/ISSNe:
- 0020-1324, 1943-3654
- Tipo:
- Article
- Páginas:
- 1831-1839
- PubMed:
- 34290078
- Factor de Impacto:
- 0,670 SCImago ℠
- Cuartil:
- Q2 SCImago ℠
RESPIRATORY CARE DAEDALUS ENTERPRISES INC
Citas Recibidas en Web of Science: 18
Documentos
- No hay documentos
Filiaciones
Keywords
- COVID-19, SARS-CoV-2, combined therapy, continuous positive airway pressure, high-flow nasal cannula, hypoxemic respiratory failure
Cita
Colaianni N,Montiel G,Castro M,Siroti C,Laura M,Toledo A,Haedo S,Previgliano I,MAZZINARI G,MIGUEL ALONSO J. Combined Noninvasive Respiratory Support Therapies to Treat COVID-19. Respir. Care. 2021. 66. (12):p. 1831-1839. IF:2,339. (4).
Portal de investigación